Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Suzuken Co ( (JP:9987) ) has shared an announcement.
Suzuken Co., Ltd. reported its consolidated financial results for the three months ending June 30, 2025, showing a slight increase in net sales by 1.8% year-on-year. Despite the rise in operating and ordinary profit, the profit attributable to owners of the parent decreased by 23.8%. The company maintains a stable financial position with total assets of ¥1,146,413 million and a capital adequacy ratio of 35.1%. The forecast for the fiscal year ending March 31, 2026, anticipates a modest increase in net sales but a decline in profits, reflecting challenges in maintaining profitability.
The most recent analyst rating on (JP:9987) stock is a Hold with a Yen5730.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. operates in the pharmaceutical distribution industry, primarily focusing on the distribution of pharmaceutical products and medical devices. The company is listed on multiple exchanges including the Tokyo Stock Exchange and has a significant presence in the Japanese market.
Average Trading Volume: 202,369
Technical Sentiment Signal: Buy
Current Market Cap: Yen340.9B
Learn more about 9987 stock on TipRanks’ Stock Analysis page.